EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

India Drafts Instant Licence Suspension for Substandard Drugs - India’s Union Health Ministry has proposed a sweeping change to how the country handles substandard medicines: instead of issuing a show-cause notice first and suspending a manufacturing licence later, regulators would be able to suspend that licence immediately the moment a government laboratory declares a drug Not of Standard Quality (NSQ) on one of five […]
NPPA Cancer Drug Price List Nears 1,136 Entries Before Nov 9 - India’s cancer drug price reset enters its final week with a discrepancy that patients and buyers should understand before November 9, 2026. The National Pharmaceutical Pricing Authority (NPPA) has been updating its revised maximum retail price (MRP) schedule for non-scheduled anti-cancer medicines in rolling instalments — and the headline count the regulator cites publicly is […]
CDSCO Tightens Solvent Tracing: Batch-Wise NOC Before Sale - India’s drug regulator has put the pharmaceutical supply chain on notice. A CDSCO communication dated 27 October 2026 directs State and Union Territory Drug Controllers to ensure that no batch of a specified high-risk pharmaceutical-grade solvent leaves a factory without being registered on the ONDLS portal and cleared with a system-generated No Objection Certificate (NOC). […]
NPPA Caps Cancer Drug Trade Margin at 30% From November 9 - India’s drug pricing authority has capped trade margins on a basket of anti-cancer medicines at 30 percent of the maximum retail price, with revised rates taking effect on November 9, 2026. The order from the National Pharmaceutical Pricing Authority (NPPA) revises ceiling prices across hundreds of brand packs and is expected to cut some maximum […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us